• The U.S. Food and Drug Administration (FDA) has proposed a new policy that would lift the lifetime ban on blood donations from gay and bisexual men. This change would also apply to tissue donations, allowing these individuals to donate tissues such as corneas, skin, and bone. The new policy aims to focus on individual risk assessments rather than blanket bans based on sexual orientation.

• The proposed policy change comes after years of advocacy and research showing that the current lifetime deferral for gay and bisexual men is not scientifically justified. The new policy would require potential donors to be screened for high-risk sexual behaviors, regardless of their sexual orientation. This aligns with the FDA's goal of ensuring the safety of the blood and tissue supply while reducing discrimination.

• The policy change is welcomed by LGBTQ+ advocates and health organizations, who have long argued that the existing ban was outdated and discriminatory. They believe the new approach will increase the pool of potential donors and improve access to life-saving and life-enhancing tissues and organs. The FDA's proposal is currently open for public comment, and the agency plans to finalize the new policy in the coming months.